CLINICAL_TRIALS
trial_result
· 2022-09-10
Clinical Trial Update: An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus [Phase 2]
Summary
Phase 2 trial evaluating BMS-986165 in systemic lupus erythematosus has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2022-09-10